糖耐量受损
医学
胰岛素抵抗
内科学
糖尿病
体质指数
内分泌学
背景(考古学)
生物
古生物学
作者
Antoinette Cameron‐Pimblett,Clementina La Rosa,Melanie Davies,Jenifer P. Suntharalingham,Miho Ishida,John C. Achermann,Gerard S. Conway
标识
DOI:10.1210/clinem/dgae357
摘要
Abstract Context Diabetes mellitus (DM) risk factors in Turner Syndrome (TS) may include autoimmunity, obesity, beta-cell dysfunction, genetic predisposition and insulin resistance (IR). Objective Evaluate glucose tolerance and DM risk factors in adults with TS. Design A single centre study with two phases. To determine the prevalence of DM and to assess diabetes risk markers comparing women with TS with and without impaired glucose tolerance (IGT). Setting Tertiary referral center, University College Hospitals. Patients 106 Women with TS (age range 18–70 years) undergoing annual health surveillance. Interventions Participants underwent oral glucose tolerance tests (OGTT), with additional samples for autoimmunity and genetic analysis. Main Outcome Measure Glucose tolerance, insulin, autoimmune and single nucleotide polymorphism (SNP) profile. Results OGTT screening showed that those without a previous DM diagnosis, 72.7% had normal glucose tolerance, 19.5% had IGT, and 7.6% were newly diagnosed with DM. OGTT identified more cases of DM than HbAc1 sampling alone. Women with IGT or DM were older, with higher body mass index and IR. No association was found between autoimmune markers GAD, IA-2 and ZnT8, risk karyotypes or selected SNPs and DM. In DM cases, GAD positivity was associated with requirement for insulin therapy. The median age of onset of the diagnosis of DM was 36 years (range 11-56). Conclusions In the spectrum of DM subtypes, TS-associated DM lies between type 1 and type 2 DM with features of both. Key factors include weight and IR. Assessing C-peptide or GAD antibodies may aid future insulin requirement.
科研通智能强力驱动
Strongly Powered by AbleSci AI